In summary, analysis of our own TMA and publicly available data showed that cGAS-STING inflammatory signaling was correlated with higher immune cell infiltration and better response to immune checkpoint inhibitor treatment in breast cancer patients. The gene discussed is STING1; the disease is breast cancer.